Beijing Scitop Bio Tech Co Ltd - Asset Resilience Ratio

Latest as of June 2026: 17.43%

Beijing Scitop Bio Tech Co Ltd (300858) has an Asset Resilience Ratio of 17.43% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Scitop Bio Tech Co Ltd (300858) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥353.57 Million

≈ $51.74 Million USD Cash + Short-term Investments

Total Assets

CN¥2.03 Billion

≈ $296.79 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Beijing Scitop Bio Tech Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300858 total asset value.

Liquid Assets Composition Over Time

This chart breaks down Beijing Scitop Bio Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read how much debt does Beijing Scitop Bio Tech Co Ltd carry for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥353.57 Million	17.43%
Total Liquid Assets	CN¥353.57 Million	17.43%

Asset Resilience Insights

Good Liquidity Position: Beijing Scitop Bio Tech Co Ltd maintains a healthy 17.43% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Beijing Scitop Bio Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Scitop Bio Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Beijing Scitop Bio Tech Co Ltd (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Beijing Scitop Bio Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	5.46%	CN¥110.21 Million ≈ $16.13 Million	CN¥2.02 Billion ≈ $295.43 Million	-10.03pp
2024-12-31	15.49%	CN¥296.73 Million ≈ $43.42 Million	CN¥1.92 Billion ≈ $280.31 Million	-19.61pp
2023-12-31	35.10%	CN¥635.26 Million ≈ $92.96 Million	CN¥1.81 Billion ≈ $264.87 Million	+19.39pp
2022-12-31	15.70%	CN¥281.17 Million ≈ $41.14 Million	CN¥1.79 Billion ≈ $262.01 Million	+6.91pp
2021-12-31	8.80%	CN¥91.55 Million ≈ $13.40 Million	CN¥1.04 Billion ≈ $152.29 Million	-8.06pp
2020-12-31	16.85%	CN¥168.40 Million ≈ $24.64 Million	CN¥999.25 Million ≈ $146.22 Million	--

pp = percentage points

About Beijing Scitop Bio Tech Co Ltd

SHE:300858 China Biotechnology

Market Cap

$553.30 Million

CN¥3.78 Billion CNY

Market Cap Rank

#11819 Global

#3394 in China

Share Price

CN¥14.35

Change (1 day)

+0.63%

52-Week Range

CN¥13.03 - CN¥25.45

All Time High

CN¥35.93